Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Sales | 167 | 397 | 150 | 95 | 0 |
| Cost of Goods | 216 | 416 | 123 | 80 | N/A |
| Gross Profit | -49 | -19 | 27 | 15 | N/A |
| Operating Expenses | 5,093 | 3,837 | 3,579 | 22,012 | 2,461 |
| Operating Income | -4,926 | -3,440 | -3,429 | -21,917 | -2,461 |
| Other Income | 318 | 187 | 170 | 95 | 63 |
| Pre-tax Income | -4,608 | -3,253 | -3,259 | -21,822 | -2,398 |
| Income Tax | N/A | N/A | N/A | 1 | -143 |
| Net Income Continuous | -4,608 | -3,253 | -3,259 | -21,823 | -2,255 |
| Net Income | $-4,608 | $-3,253 | $-3,259 | $-21,823 | $-2,255 |
| EPS Basic Total Ops | -0.10 | -0.11 | -0.11 | -0.78 | -0.10 |
| EPS Basic Continuous Ops | -0.10 | -0.11 | -0.11 | -0.78 | -0.09 |
| EPS Diluted Total Ops | -0.10 | -0.11 | -0.11 | -0.78 | -0.10 |
| EPS Diluted Continuous Ops | -0.10 | -0.11 | -0.11 | -0.78 | -0.09 |
| EBITDA(a) | $-4,887 | $-3,400 | $-3,388 | $-21,882 | $-2,426 |